Cas:12244-57-4 Sodium aurothiomalate manufacturer & supplier

Chemical Name:Sodium aurothiomalate

CAS.NO:12244-57-4

Synonyms:kidon;autm;miochrysin;MFCD00064304;Miocrisina;chrysothios;tauredon;myochrysine;myocrisin;EINECS 235-479-7

Molecular Formula:C₄H₃AuNa₂O₄S

Molecular Weight:390.07500

HS Code:2930909090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:105.56000

Exact Mass:389.92100

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like kidon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 235-479-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,myochrysine Use and application,MFCD00064304 technical grade,usp/ep/jp grade.

Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. Sodium aurothiomalate manufacturer The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.” Sodium aurothiomalate supplier At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. Sodium aurothiomalate vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. Sodium aurothiomalate factory The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.”